For the Quarter Ending March 2026
Atenolol Prices in North America
- In United States, the Atenolol Price Index rose quarter-over-quarter in Q1 2026, driven by surging propylene costs.
- The Atenolol Production Cost Trend increased in March 2026 as a 4.0% PPI rise elevated precursor expenses.
- The Atenolol Demand Outlook strengthened in March 2026, bolstered by 4.0% retail sales growth ensuring prescription fulfillment.
- A stable 4.3% unemployment rate in March 2026 sustained insurance coverage, driving steady Atenolol prescription adherence.
- Consumer confidence reached 91.8 in March 2026, encouraging routine medical check-ups and supporting robust Atenolol demand.
- Industrial production grew 0.7% in March 2026, limiting surplus intermediate supply and supporting Atenolol pricing power.
- The Manufacturing Index expanded in March 2026, ensuring steady intermediate production and reliable Atenolol availability.
- The Atenolol Price Forecast indicated upward pressure in Q1 2026 due to a 3.3% CPI increase.
Why did the price of Atenolol change in March 2026 in North America?
- Upstream propylene feedstock costs surged sequentially in Q1 2026 due to global supply chain disruptions.
- Global ammonia availability tightened significantly in Q1 2026 following planned and unplanned facility shutdowns.
- United States pharmaceutical imports faced new tariff pressures in Q1 2026, impacting active ingredient trade.
Atenolol Prices in APAC
- In China, the Atenolol Price Index rose quarter-over-quarter in Q1 2026, driven primarily by escalating upstream feedstock expenses.
- The Producer Price Index increased by 0.5% in March 2026, reflecting higher Atenolol Production Cost Trends.
- Consumer Price Index grew 1.0% in March 2026, supporting stable Atenolol Demand Outlook for cardiovascular medications.
- Industrial production expanded 5.7% year-over-year in March 2026, ensuring steady availability of intermediates for Atenolol synthesis.
- Retail sales grew slowly at 1.7% in March 2026, slightly limiting bulk pharmacy inventory stocking activities.
- The urban unemployment rate reached 5.4% in March 2026, negatively impacting branded retail pharmaceutical purchasing power.
- Production costs for key feedstock epichlorohydrin surged during Q1 2026 due to escalating upstream propylene expenses.
- Buyers initiated strategic inventory buildup in Q1 2026, anticipating an upward Atenolol Price Forecast amid constraints.
- Export dynamics shifted in February 2026 after India imposed anti-dumping duties on Chinese isopropylamine chemical imports.
Why did the price of Atenolol change in March 2026 in APAC?
- Upstream propylene supply severely constrained in Q1 2026 as dehydrogenation units operated at reduced capacities.
- Regional epichlorohydrin supply tightened during Q1 2026 due to scheduled maintenance turnarounds at chlorohydrination plants.
- Pharmaceutical sector demand strengthened in Q1 2026, driven by surging cross-border outlicensing deal value activities.
Atenolol Prices in Europe
- In Germany, the Atenolol Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- In March 2026, Germany's CPI rose 2.7% year-over-year, while producer prices declined slightly by 0.2%.
- The manufacturing index expanded in March 2026, despite stagnant industrial production at 0.0% in February 2026.
- Stable unemployment at 4.2% and a 0.7% retail sales increase in February 2026 supported Atenolol demand.
- Negative consumer confidence at -24.7 in March 2026 pressured branded Atenolol pricing, favoring generic alternatives.
- The Atenolol production cost trend surged in March 2026 as naphtha and propylene prices spiked.
- Raw material inventories tightened in March 2026 following early Q1 2026 surpluses and maritime route closures.
- The Atenolol demand outlook strengthened as pharmaceutical producer prices surged in Germany during February 2026.
- The Atenolol price forecast reflected upward pressure following severe Middle East trade disruptions in March 2026.
Why did the price of Atenolol change in March 2026 in Europe?
- Naphtha and propylene feedstock costs surged in Europe during March 2026 due to geopolitical tensions.
- Severe Middle East export disruptions tightened raw material availability for Atenolol precursors during March 2026.
- Strong pharmaceutical sector activity in Germany during February 2026 drove downstream demand for active ingredients.
For the Quarter Ending December 2025
Atenolol Prices in North America
- In United States, the Atenolol Price Index rose quarter-over-quarter in Q4 2025, influenced by increasing production costs.
- Atenolol production costs increased, driven by a 3.0% year-over-year rise in PPI in November 2025.
- Demand for Atenolol was indirectly supported by a 3.3% year-over-year increase in retail sales in November 2025.
- The Atenolol Price Forecast indicates continued upward pressure from input costs, balanced by broader chemical oversupply.
- US natural gas spot prices gradually rose in the final months of 2025, impacting Atenolol manufacturing expenses.
- Industrial production expanded by 2.0% year-over-year in December 2025, ensuring stable access to manufacturing resources.
- A 4.4% unemployment rate in December 2025 indirectly supported Atenolol demand by increasing healthcare access.
- Trade and tariff uncertainty remained a significant market trend for Q4 2025, affecting supply chain stability.
Why did the price of Atenolol change in December 2025 in North America?
- Production costs increased due to a 3.0% year-over-year rise in PPI in November 2025.
- Energy expenses for Atenolol manufacturing rose as US natural gas spot prices climbed in Q4 2025.
- The broader chemical industry experienced uneven demand and global oversupply during Q4 2025.
Atenolol Prices in Europe
- In Germany, the Atenolol Price Index fell in Q4 2025, driven by intensified competitive pressures from abroad in October 2025.
- Atenolol production costs declined in December 2025, as producer prices (PPI) decreased by 2.5% year-on-year.
- Demand for Atenolol remained stable in Q4 2025, supported by demographic tailwinds, including an aging population.
- The Manufacturing Index showed a contracting trend in December 2025, indicating a weaker economic environment for the chemical sector.
- Industrial production in Germany increased by 0.8% year-on-year in October 2025, supporting a stable manufacturing backdrop.
- Elevated raw material costs challenged Germany's chemical industry throughout Q4 2025, despite CPI rising 1.8% year-on-year in December 2025.
- European gas stockpiles tightened by December 2025, reflecting a less comfortable energy supply situation for early winter.
- The Atenolol price forecast suggests continued downward pressure from global overcapacity and a strong euro in December 2025, with consumer confidence at -17.5.
Why did the price of Atenolol change in December 2025 in Europe?
- Producer prices (PPI) decreased by 2.5% year-on-year in December 2025, lowering Atenolol production costs.
- Intensified competitive pressures from abroad led chemical companies to lower price plans in October 2025.
- Global overcapacity and a strong euro strained Germany's chemicals sector in December 2025.
Atenolol Prices in APAC
- In China, the Atenolol Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer prices in December 2025.
- Atenolol production costs decreased in December 2025, with Producer Price Index falling 1.9% year-over-year.
- Demand for Isopropylamine, a key Atenolol precursor, strengthened in 2025, supporting overall demand.
- China's Manufacturing Index expanded in December 2025; industrial production rose 5.2% year-over-year.
- Widespread chemical industry overcapacity and new capacities lengthened Atenolol supply throughout 2025.
- China's medicine exports, including Atenolol APIs, steadily increased during the first eleven months of 2025.
- The Consumer Price Index rose 0.8% year-over-year in December 2025, indicating stable consumer inflation.
- Retail sales grew 0.9% year-over-year in December 2025, while unemployment stood at 5.1%.
- Atenolol price forecast suggests continued downward pressure due to falling selling prices in December 2025.
Why did the price of Atenolol change in December 2025 in APAC?
- Producer Price Index declined 1.9% in December 2025, reducing Atenolol production costs.
- Widespread chemical overcapacity and new capacities lengthened Atenolol supply throughout 2025.
- Selling prices for manufactured goods continued to fall in China in December 2025, impacting market.
For the Quarter Ending September 2025
Atenolol Prices in North America
- In the United States, the Atenolol Price Index rose in Q3 2025, driven by rising production costs and constrained supply.
- Atenolol production costs increased in Q3 2025, influenced by rising PPI (2.6% in August 2025).
- Demand for Atenolol was supported by an upward pharmaceutical sector trajectory during Q3 2025.
- Phenol feedstock costs for Atenolol production experienced upward movement in North America in Q3 2025.
- US natural gas prices saw a year-over-year uptick during Q3 2025, raising Atenolol manufacturing expenses.
- Overall inventories decreased in August and September 2025, indicating tighter Atenolol market conditions.
- Strong retail sales (5.42% in September 2025) and low unemployment (4.3% in September 2025) supported healthcare spending.
- Constrained phenol supply in Q3 2025 due to turnarounds impacted Atenolol production capacity.
- Rising CPI (3.0% in September 2025) signaled higher operational costs for Atenolol manufacturers.
- Industrial production showed a slight 0.1% year-over-year growth in September 2025.
Why did the price of Atenolol change in September 2025 in North America?
- Rising PPI (2.6% in August 2025) and natural gas prices increased Atenolol production costs.
- Constrained phenol supply in Q3 2025 due to turnarounds impacted Atenolol availability.
- Strong pharmaceutical sector activity and increased drug approvals drove Atenolol demand.
Atenolol Prices in Europe
- In Germany, Atenolol Price Index rose in Q3 2025, driven by strengthening pharmaceutical demand and tightening regional supply.
- Atenolol production costs were influenced by a -1.7% PPI in September 2025 and declining propylene feedstock costs.
- Operating costs for Atenolol production increased due to a 2.4% CPI in September 2025 and elevated energy prices.
- Atenolol demand outlook strengthened in Q3 2025, supported by an aging population and low 3.9% unemployment.
- Regional supply tightened in Q3 2025 due to plant closures and a -1.0% industrial production decline.
- Chemical industry inventories, including raw materials and finished goods, shrank in Q3 2025 from accelerating destocking.
- The Manufacturing Index was contracting in September 2025, indicating a slowdown in the broader German industrial sector.
- Modest 0.8% retail sales growth in September 2025 supported the economy, despite consumer confidence at -23.6.
Why did the price of Atenolol change in September 2025 in Europe?
- Pharmaceutical demand strengthened in Q3 2025, supported by a low 3.9% unemployment rate.
- Production costs were influenced by a -1.7% PPI in September 2025 and elevated energy prices.
- Regional supply tightened due to plant closures in Q3 2025, while inventories shrank from destocking.
Atenolol Prices in APAC
- In China, the Atenolol Price Index faced downward pressure in Q3 2025, influenced by a contracting Producer Price Index (-2.3% in September 2025).
- Atenolol production costs rose during Q3 2025, driven by elevated naphtha costs in August and increasing phenol feedstock prices.
- Demand for Atenolol was supported in Q3 2025 by an aging population and an expanding non-manufacturing sector.
- Raw material inventories for manufacturing, including Atenolol inputs, tightened throughout Q3 2025, indicating supply constraints.
- China's industrial production increased by 6.5% year-on-year in September 2025, supporting a stable pharmaceutical manufacturing environment.
- Consumer confidence remained pessimistic in September 2025 (index 89.6), influencing patient willingness for medical care.
- The Manufacturing Index showed sustained contraction in Q3 2025, though with gradual improvement, affecting supply chain stability.
- Retail sales grew by 3.0% year-on-year in September 2025, supporting consumer spending and patient affordability for Atenolol.
Why did the price of Atenolol change in September 2025 in APAC?
- Producer Price Index contracted by 2.3% year-on-year in September 2025, reducing overall manufacturing costs.
- Phenol feedstock benzene prices in Northeast Asia inched up in August, elevating Atenolol production expenses.
- Consumer Price Index contracted by 0.3% year-on-year in September 2025, signaling deflationary pressure.
For the Quarter Ending December 2022
North America
The North American market for Atenolol API witnessed turbulence during the fourth quarter of 2022. Due to high manufacturing costs, numerous logistical challenges, and increasing inflation, prices started to rise in Q4 2022 and continued to do so throughout the second month of the fourth quarter, with values accessed at USD 47650/MT CFR New York.
Rising transportation costs and port congestion at the main ports also helped to keep the market situation positive. In addition, the market situation improved due to the decrease in API output driven by higher energy prices. Later in December, prices started to drop due to easing inflation and a drop in end-user sector demand as the holiday season drew near. In December, the Atenolol API settlement price fell to USD 46355/MT CFR in New York.
Asia
The fourth quarter of 2022 was extremely volatile for the Asia Pacific Atenolol API industry. It was observed that rising end-user sector demand, several logistical difficulties, and rising inflation would cause prices to increase through the second month of the quarter. The prices accessed at the termination of the second month of Q4 were USD 40870/MT FOB Shanghai. Due to growing production costs driven by rising energy prices as well as increased domestic production to meet demand from both domestic and international markets, the market remained competitive. The strict zero covid regulations and frequent lockdowns in the Chinese regions have influenced the market. As domestic retailers had enough inventory by the end of December, the prices suddenly declined with the settlement price of USD 39655/MT FOB Shanghai.
Europe
Prices for Atenolol API fluctuated across the European region during the fourth quarter of 2022. It was observed that there was a consistent demand for Atenolol API in the pharmaceutical industry's downstream market. In the first two months of Q4 022, supply disruption and persistent port congestion in the European region led to price increases. Due to the impending Christmas season and the need to get ready for upcoming orders, retailers in Europe have decided to refill their inventories significantly. However, prices fell sharply in December due to a decline in inflation, relief from port congestion, and a minor increase in merchants' current stocks. The cost of Atenolol API was USD 48555/MT CFR Hamburg toward the end of Q4 2022.
